Naloxegol
Pharm Company: * MSN LABS PVT LTDCategory: Opioid Dependence
Naloxegol (INN; PEGylated naloxol;[1] trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation.[2] It was approved in 2014 in adult patients with chronic, non-cancer pain.[3] Doses of 25mg were found safe and well tolerated for 52 weeks.[4] When given concomitantly with opioid analgesi... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Related Brands
Drugs with the same active ingredients